Replies to post #78655 on Cytodyn Inc (CYDY)

[justdafactss]

PR says "it will be submitting".

Why not just submit it and see how it pans out.

today announced it will be submitting a protocol to the U.S. Food and Drug Administration (FDA) for a factorial design trial to compare effectiveness of leronlimab versus remdesivir and in combination with remdesivir for the treatment of COVID-19.
https://www.globenewswire.com/news-release/2020/05/18/2034806/0/en/CytoDyn-to-Prepare-a-Phase-3-Protocol-to-Submit-to-the-FDA-for-a-Three-Arm-Comparative-and-Combination-Trial-of-Leronlimab-and-Remdesivir.html

Then the disclamer-

Words and expressions reflecting optimism, satisfaction or disappointment with current prospects, as well as words such as “believes,” “hopes,” “intends,” “estimates,” “expects,” “projects,” “plans,” “anticipates” and variations thereof, or the use of future tense, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking

Laughing